Ventricular fibrillation and ventricular tachycardia post–SARS-CoV-2–targeted mRNA/viral vector vaccinationResearch Letter Published on 2023-11-022024-09-05 Journal: Heart Rhythm O2 [Category] update2024, [키워드] adverse effect SARS-CoV-2 Vaccine ventricular fibrillation ventricular tachycardia [DOI] 10.1016/j.hroo.2023.11.001 PMC 바로가기 [Article Type] Research Letter
Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021article Published on 2023-06-152024-09-05 Journal: Eurosurveillance [Category] update2024, [키워드] adverse effect COVID-19 facial paresis Guillain-barrè syndrome Neuritis vaccination [DOI] 10.2807/1560-7917.ES.2023.28.24.2200744 PMC 바로가기 [Article Type] article
Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccineShort Report Published on 2023-06-062024-09-04 Journal: Wiener Klinische Wochenschrift [Category] 대상포진, [키워드] adverse effect COVID-19 vaccine hemolytic anemia Necrosis renal failure [DOI] 10.1007/s00508-023-02225-0 PMC 바로가기 [Article Type] Short Report
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?Pharmacovigilance Published on 2023-02-222024-09-05 Journal: Thérapie [Category] update2024, [키워드] adverse effect COVID-19 vaccine Détection de signal Drug safety Effet indésirable pharmacovigilance Sécurité des médicaments signal detection Vaccin COVID-19 [DOI] 10.1016/j.therap.2023.02.009 PMC 바로가기 [Article Type] Pharmacovigilance
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases seriesPharmacovigilance Published on 2023-02-162024-09-05 Journal: Thérapie [Category] update2024, [키워드] adverse effect COVID-19 vaccine Drug safety peripheral facial palsy pharmacovigilance [DOI] 10.1016/j.therap.2023.02.005 PMC 바로가기 [Article Type] Pharmacovigilance
Reactive arthritis after vaccination against SARS-CoV-2: A case series and a mini-reviewCoronavirus Published on 2023-02-062024-09-05 Journal: Human vaccines & immunotherapeutics [Category] update2024, [키워드] adverse effect COVID vaccination Reactive arthritis [DOI] 10.1080/21645515.2023.2173912 PMC 바로가기 [Article Type] Coronavirus
Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic reviewCOVID-19 백신에 대한 무작위 대조 시험의 보고 품질 평가: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] 임상, [키워드] adverse effect Analysis analysis of variance Assessing CONSORT CONSORT statement controlled trials COVID-19 COVID-19 vaccine COVID-19 vaccines criteria current database effective evaluated Evidence groups independent indicate indicated median Mortality no significant difference predicted Randomized Randomized controlled trial Randomized controlled trials RCT RCTs reported Reporting Reporting quality review Standard systematic review Univariate analysis variance variety [DOI] 10.1080/21645515.2022.2031453 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19Article Published on 2022-11-302022-11-15 Journal: Human vaccines & immunotherapeutics [Category] SARS, 진단, [키워드] adverse effect animal models antibody Antibody titer BALB/c mice changes in class COVID-19 COVID-19 vaccine demonstrated did not produce ELISA ENhance enzyme-linked immunosorbent ferrets Gender general condition GMT group growth hamster hamsters Health histology immune response immunization immunogenicity Inactivated vaccine injection internal organ Kazakhstan lowest microneutralization MNA nontoxic preclinical trials rhesus macaque Safety significant difference statistically significant Toxicity Vaccine were assessed [DOI] 10.1080/21645515.2022.2087412 PMC 바로가기
Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as MechanismArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] 진단, [키워드] Activation acute respiratory syndrome adverse effect chilblains coronavirus COVID disease infusion interferon mechanism Pfizer presenting rituximab significantly skin lesion Toe Vaccine worsened [DOI] 10.1093/milmed/usab314 PMC 바로가기
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 VaccineArticle Published on 2022-10-252022-11-15 Journal: ACS Nano [Category] COVID19(2023년), SARS, 변종, 비임상, 진단, [키워드] ACM acute respiratory syndrome adverse effect airway antibodies antibody antigen presenting cells artificial Beta Beta spike C57BL/6 cell membrane clinical symptom clinical trial component conditions coronavirus coronavirus disease COVID-19 CpG cross-neutralizing current delivery of cargo dendritic cells dose doses evaluate evaluated Formulation generate Generation Good hamster hamsters immune responses immunization immunogenic induce Infection initiated interval intranasal mice neutralize neutralizing antibody neutralizing responses New omicron Phase 1 polymersome Practice PROTECT reduction repeated Safety SARS-CoV-2 second serum IgG spike Spike protein Spike-based vaccine Support Toxicity upper respiratory tract Vaccine variants viral clearance Viral load virus weight loss wild type [DOI] 10.1021/acsnano.2c06350 PMC 바로가기